Login or sign up
For business

Glycardial diagnostics

4.3· 8 reviews
Average ratingGreat
4.3/ 5

Based on 8 reviews

550%
425%
325%
20%
10%
Ask AI

Questions about Glycardial diagnostics

Based on 8 reviews, listing data and website checks · updated 6 days ago

What is Glycardial diagnostics?

Glycardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC). It develops a novel in vitro diagnostic device for myocardial ischemia. The technology detects Apo J-Glyc in blood as a biomarker for early diagnosis and predicting patient evolution after an ischemic event.

Where is Glycardial Diagnostics based and what industry does it operate in?

The company is located in Barcelona, Spain, and operates within the biotechnology industry. Their primary focus is on creating diagnostic tools for cardiac health.

How recent are the reviews and what is the current rating?

The business has been active since at least 2023, as evidenced by reviews posted that year. It currently holds a Trustburn rating of 4.3 out of 5 stars based on 8 customer reviews.

What specific aspects of the service do reviewers consistently praise?

Customers frequently praise the accuracy of the tests and the friendliness of the staff. Many reviewers also highlight the efficiency of the testing process and the timeliness of receiving results.

What themes emerge from the experiences shared by multiple reviewers?

Some reviewers mention that the tests were quick and that the staff made them feel comfortable throughout the process. Others noted the precision with which the tests were conducted.

Which countries and regions does Glycardial Diagnostics serve?

The business operates in the country code ES, which corresponds to Spain, with its main location in Barcelona. They serve the local market for biotechnology and diagnostic solutions.

How can a potential customer get started or book a test?

To get started, individuals can visit glycardial.com for more information. The company provides cardiac testing services, and the process involves quick tests with accurate results provided in a timely manner.

How can I contact Glycardial diagnostics?

You can reach Glycardial diagnostics by e-mail at info@glycardial.com.

What is the official website of Glycardial diagnostics?

The official website of Glycardial diagnostics is glycardial.com.

Is Glycardial diagnostics on social media?

Glycardial diagnostics has official profiles on Linkedin.

AI-generated from reviews on this page. Verify anything important with the company directly.

Nikisha White
Reviews 1

I recently used Glycardial Diagnostics for my cardiac testing and I couldn't be happier with the service I received. The staff was friendly, knowledgeable, and made me feel comfortable throughout the process. The tests were quick and the results were provided to me in a timely manner. I highly recommend Glycardial Diagnostics for all your cardiac testing needs.

Matthew Middel
Reviews 1

I recently had the opportunity to use Glycardial Diagnostics for my cardiac testing needs. I must say that their service was outstanding. From the moment I walked in, I was greeted warmly by the staff. The tests were conducted with precision and I didn't have to wait long for the results. I would definitely recommend Glycardial Diagnostics to anyone in need of reliable and efficient cardiac diagnostics.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Glycardial diagnostics

GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event.

Categories
Biotechnology